Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 37, 2023 - Issue 12
219
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Bisabolane-type sesquiterpenoids with potential anti-inflammatory and anti-HIV activities from the stems and leaves of Morinda citrifolia

, , , , , , , & show all
Pages 1961-1968 | Received 29 Oct 2021, Accepted 07 Aug 2022, Published online: 17 Aug 2022
 

Abstract

The phytochemical study on the stems and leaves of Morinda citrifolia L. resulted in the isolation of a new naturally occurring bisabolane-type sesquiterpenoid, morincitrinoid A (1), together with five known analogues (26). The chemical structure of 1 was elucidated by comprehensive spectral analyses. The known compounds 26 were identified by comparing their spectral data with those reported in the literature, which were isolated from M. citrifolia for the first time. In addition, the anti-inflammatory and anti-HIV activities of compounds 16 were evaluated in vitro. Compounds 16 displayed significant inhibitory activities on NO (nitric oxide) production induced by lipopolysaccharide in mouse macrophage RAW 264.7 cells with IC50 values ranging from 0.98 ± 0.07 to 6.32 ± 0.11 μM, which was comparable to hydrocortisone. Meanwhile, compounds 16 showed remarkable anti-HIV-1 reverse transcriptase (RT) effects with the EC50 values ranging from 0.16 to 6.29 μM.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was financially supported by the Key Research and Development Project of Hainan Province (Nos. ZDYF2019116 and ZDYF2019049), the National Natural Science Foundation of China (Nos. 21967008, 22067005 and 32070390), the Natural Science Foundation of Hainan Province (Nos. 2019RC198 and 220RC596) and the Key Research and Development Project of Haikou (No. 2020054 and 2017050).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.